fluorouracil has been researched along with vindesine in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (28.21) | 18.7374 |
1990's | 39 (50.00) | 18.2507 |
2000's | 13 (16.67) | 29.6817 |
2010's | 4 (5.13) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asselain, B; Blaszka, B; Brunin, F; Jaulerry, C; Jouve, M; Mosseri, V; Point, D; Rodriguez, J; Validire, P; Zafrani, B | 1 |
Chapelier, A; Dartevelle, P; Rebischung, JL; Sauvaget, J; Vannetzel, JM | 1 |
Armand, JP; Bachouchi, M; Cvitkovic, E; Guillot, T; Kac, J; Luboinski, B; Munck, JN; Spielmann, M; Tellez-Bernal, E | 1 |
Bonichon, F; Chauvergne, J; Dilhuydy, JM; Durand, M; Mauriac, L | 1 |
Kanamaru, R; Kikuchi, H | 1 |
Beutter, P; Calais, G; Garand, G; Le Floch, O; Reynaud-Bougnoux, A | 1 |
Endo, M; Ito, K; Sunagawa, M; Suzuki, T | 1 |
Armand, JP; Belehradek, M; Cvitkovic, E; De Vathaire, F; Domenge, C; Recondo, G; Richard, JM; Tellez-Bernal, E; Wibault, P | 1 |
Doi, R; Kihira, S; Kume, T; Nakao, M; Oshima, W; Takada, A; Takegami, E; Terazono, T | 1 |
Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T | 1 |
Campana, F; Fourquet, A; Palangié, T; Pouillart, P; Vilcoq, JR | 1 |
Bauer, J; Capasso, P; Leyvraz, S; Pasche, P; Perey, L; Savary, M | 1 |
Fujita, J; Saijo, N | 1 |
Inoue, F; Mimura, H; Miyake, M; Mori, T; Orita, K; Takeda, I; Tanaka, N | 1 |
Ballon, G; Calais, G; Goga, D; Le Flock, O | 1 |
Haegele, P; Janser, JC; Navarrete, E; Pusel, J; Rodier, D; Rodier, JF | 1 |
Belli, L; Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Livartowski, A; Mosseri, V; Palangie, T; Scholl, S; Vedrenne, J | 1 |
Fujita, F; Fujita, M; Inaba, H; Sakamoto, Y; Shimozuma, K; Taguchi, T | 1 |
Beyer, JH; Emrich, D; Holtkamp, W; Kneba, M; Luig, H; Marschner, N; Nagel, GA; Rauschning, W; Unger, C; Wander, HE | 1 |
Chauvergne, J; David, M; Durand, M; Hoerni, B; Mauriac, L | 1 |
Bates, TD; Edelstyn, GA; Hill, BT; Macrae, KD; Martin, WM; Nicol, NT; Ostrowski, MJ; Spittle, MF | 1 |
Iizuka, T | 1 |
Bertin, F; Elias, D; Eschwege, F; Girinsky, T; Kac, J; Lasser, P; Leclercq, B; Nitenberg, G; Rougier, P; Spielmann, M | 1 |
Fountzilas, G; Gratzner, H; Lim, LO; Yunis, AA | 1 |
de Jong, M; Hillen, H; Planting, A | 1 |
Bastian, G; Berthau, N; Coutant, M; Demarcq, C; Dorval, T; Fasano, M; Garcia-Giralt, E; Jouve, M; Palangie, T; Vedrenne, J | 1 |
Haeno, Y; Hara, S; Kayama, H; Kurooka, K; Mori, K; Sagara, N; Yasutomi, M | 1 |
Blijham, GH; Fiolet, HH; Hupperets, PS; Janssen, JH; van Deijk, WA | 1 |
Gunstream, SR; McMahon, LJ; Seidenfeld, JJ; Sobonya, RE | 1 |
Kelsen, D | 1 |
Bains, M; Hilaris, B; Kelsen, D; Martini, N | 1 |
Carlin, DA; Grozea, PN; Miller, TP; Weick, JK | 1 |
Kahle, H; Valet, G; Warnecke, HH | 1 |
Bedikian, AY; Bennetts, RW; Bodey, GP; Karlin, DA; Stroehlein, JR; Valdivieso, M | 1 |
Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M | 1 |
Ando, N; Iizuka, T; Kitajima, M; Ozawa, S | 1 |
Berchier, MC; Bureau, G; Dabouis, G; Klastersky, J; Libert, P; Ries, F; Schmerber, J; Sculier, JP; Thiriaux, J; Van Cutsem, O | 2 |
Carlomagno, C; De Laurentiis, M; De Placido, S; Lauria, R; Marinelli, A; Morabito, A; Pagliarulo, C; Perrone, F; Petrella, G; Varriale, E | 1 |
Hirano, S; Iguchi, H; Izumi, H; Matsushita, Y; Takeuchi, T; Tone, H | 1 |
Hagiwara, Y; Kanayama, T; Kobayashi, H; Koezuka, M; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M | 1 |
Berger, C; Body, G; Bougnoux, P; Calais, G; Chapet, S; Descamps, P; Lansac, J; Le Floch, O; Reynaud-Bougnoux, A | 1 |
Bauer, J; Bernasconi, S; Leyvraz, S; Monnier, P; Pasche, P | 1 |
Cerrina, J; Chapelier, AR; Dartevelle, PG; Ladurie, FL; Lenot, B; Macchiarini, P; Monnet, I; Parquin, F; Rebischung, JL; Vannetzel, JM | 1 |
Azli, N; Cvitkovic, E; de Cremoux, H; Monnet, I; Riggi, M; Ruffie, P; Saltiel, JC; Villalobos, W; Voisin, S | 1 |
Hirayama, K; Hoshino, A; Mori, S; Nishihira, T; Shineha, R | 1 |
Fujita, H; Kakegawa, T; Shinozaki, K; Yamana, H | 1 |
Body, G; Bougnoux, P; Calais, G; Chapet, S; Descamps, P; Fignon, A; Lansac, J; Lemarié, E; Reynaud-Bougnoux, A; Turgeon, V | 1 |
Higashino, K; Igarashi, T; Ikegami, H; Kawase, T; Komuta, K; Nakamura, S; Nakano, T; Nishikawa, H; Tachibana, T; Yokota, S; Yoshida, M | 1 |
Armand, JP; Bernal, ET; Cvitkovic, E; Domenge, C; Guillot, T; Janot, F; Sigal, R; Wibault, P | 1 |
Fujita, A; Sekine, K; Sohda, T; Tagaki, S; Takabatake, H | 1 |
Eguchi, R; Hayashi, K; Ide, H; Nakamura, T | 1 |
Furukawa, K; Hayashi, N; Itabashi, T; Morishima, Y; Nakajima, N; Nitta, H; Ohtsubo, Y; Sano, W; Sugiura, T; Takagi, K; Tashiro, T; Toyoda, Y; Yamamori, H | 1 |
Navarra, P; Preziosi, P | 1 |
Fietkau, R; Iro, H; Kirschner, MJ; Sauer, R; Waldfahrer, F | 1 |
Arriagada, R; Baldeyrou, P; Bretel, JJ; Grunenwald, D; Le Chevalier, T; Le Péchoux, C; Pellae-Cosset, B; Ruffié, P | 1 |
Agostara, B; Amoroso, D; Boccardo, F; Farris, A; Gallo, L; Mesiti, M; Pacini, P; Perrotta, A; Rubagotti, A; Sismondi, P; Villa, E | 1 |
Aoki, K; Ikeda, K; Ishida, K; Iwaya, T; Kimura, Y; Koeda, K; Ogasawara, S; Ohtsuka, K; Saito, K; Sato, N | 1 |
Bonvoisin, S; Desseigne, F; Gerard, JP; Morignat, E; Mornex, F; Pommier, P; Taieb, S; Vaillant, E | 1 |
Isogaki, J; Kawabe, A; Kazui, T; Kobayashi, T; Nishimura, T; Nozue, M; Wada, H; Yoshida, M | 1 |
Belpomme, D; Benmiloud, M; Facchini, T; Frenay, M; Gauthier, S; Goudier, MJ; Gousset, C; Krakowski, I; Marié, FN; Netter-Pinon, G; Pujade-Lauraine, E; Sturtz, F | 1 |
Doddoli, C; Fuentes, P; Giudicelli, R; Papazian, L; Reynaud-Gaubert, M; Thomas, P | 1 |
Beuzeboc, P; Chauveinc, L; Clough, KB; Cosset, JM; de la Rochefordière, A; Guyonnet, M; Mouret-Fourme, E; Nguyen, D | 1 |
Fukuyama, Y; Ichinose, Y; Yamaguchi, M | 1 |
Chen, W; Guo, W; Lin, L; Xu, Q; Zhou, X | 1 |
Heinemann, V | 1 |
Hejna, M; Raderer, M | 1 |
Boku, N; Fukutomi, A; Hasuike, N; Hironaka, S; Inui, T; Ono, H; Onozawa, Y; Yamaguchi, Y; Yamazaki, K; Yasui, H; Yoshino, T | 1 |
Andersen, PK; Cortese, G; Nielsen, D; Nielsen, G; Ryberg, M; Skovsgaard, T | 1 |
Huang, G; Lartigau, E; Shi, D; Shi, G; Zhang, J | 1 |
Abrous-Anane, S; Bollet, MA; Campana, F; Daveau, C; Dendale, R; Fourquet, A; Gautier, C; Kirova, YM; Pierga, JY; Reyal, F; Savignoni, A | 1 |
Akiyoshi, K; Hamaguchi, T; Hosokawa, A; Iwasa, S; Kato, K; Nakajima, TE; Nishitani, H; Ogawa, K; Shimada, Y; Sugiyama, T; Ueno, T; Yamada, Y | 1 |
Bella, AE; Fu, JH; Hu, Y; Luo, KJ; Wen, J; Xie, X; Yang, F; Yang, H; Zhang, SS | 1 |
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
10 review(s) available for fluorouracil and vindesine
Article | Year |
---|---|
[Concomitant association of radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Inflammation; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Vindesine | 1991 |
[Gastric metastases of cancer of the breast. Apropos of a case. Review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Gastroscopy; Humans; Middle Aged; Mitomycins; Mitoxantrone; Omentum; Radiography; Stomach Neoplasms; Tamoxifen; Vindesine | 1989 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine | 1984 |
Combined-modality therapy of esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Doxorubicin; Esophageal Neoplasms; Esophagus; Fluorouracil; Humans; Methotrexate; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Time Factors; Vinblastine; Vindesine | 1984 |
[Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Humans; Radiotherapy, Adjuvant; Vindesine | 1995 |
[Treatment of patients with recurrent esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Survival Rate; Vindesine | 1998 |
[Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Pneumonectomy; Radiotherapy, Adjuvant; Vindesine | 2003 |
Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Enzyme Inhibitors; Epirubicin; Fluorouracil; Gemcitabine; Humans; Leucovorin; Paclitaxel; Taxoids; Trastuzumab; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2003 |
[Neoadjuvant therapy for resectable esophageal cancer].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose Fractionation, Radiation; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Meta-Analysis as Topic; Neoadjuvant Therapy; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Time Factors; Vindesine | 2005 |
Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Lymphatic Metastasis; Neoplasm Staging; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 2014 |
19 trial(s) available for fluorouracil and vindesine
Article | Year |
---|---|
[Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Vindesine | 1992 |
[Phase II trial of concomitant cyclic radio-chemotherapy combination (ARCCC) in unoperable non-small cell lung cancer (CBNPCI)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Lung Neoplasms; Radiation Dosage; Vindesine | 1992 |
Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Thiotepa; Vincristine; Vindesine | 1992 |
[Concomitant association of radiotherapy and chemotherapy in inflammatory breast cancer. Initial results of phase II trial].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Inflammation; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Vindesine | 1991 |
[Induction chemotherapy of carcinomas of the oral cavity and oropharynx. Feasibility study, levels and factors of response to treatment. Apropos of 135 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Clinical Trials as Topic; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Prognosis; Remission Induction; Vincristine; Vindesine | 1987 |
[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Prospective Studies; Vindesine | 1989 |
[Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Thiotepa; Vincristine; Vindesine | 1986 |
A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prospective Studies; Random Allocation; Vincristine; Vindesine | 1987 |
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Prognosis; Survival Analysis; Vindesine | 1994 |
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Rate; Vindesine | 1995 |
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Death, Sudden, Cardiac; Fluorouracil; Heart; Humans; Lung Neoplasms; Mitomycins; Remission Induction; Survival Rate; Vindesine | 1994 |
Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Radiotherapy; Radiotherapy Dosage; Remission Induction; Stomatitis; Survival Rate; Vindesine | 1994 |
Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques)
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vindesine | 1993 |
[Surgical adjuvant therapy of carcinoma of the thoracic esophagus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Radiotherapy Dosage; Survival Rate; Vindesine | 1993 |
A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Time Factors; Vindesine | 1996 |
[Evaluation of chemotherapy for stage IV non-small cell lung cancer employing a regression tree type method for quality-adjusted survival analysis to determine prognostic factors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Fluorouracil; Humans; Ifosfamide; Length of Stay; Lung Neoplasms; Male; Middle Aged; Prognosis; Quality of Life; Regression Analysis; Survival Analysis; Vindesine | 1996 |
[Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vinblastine; Vindesine | 1997 |
Lack of effectiveness of adjuvant alternating chemotherapy in node-positive, estrogen-receptor-negative premenopausal breast cancer patients: results of a multicentric Italian study. The Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group (GROC
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Premenopause; Receptors, Estrogen; Survival Analysis; Vincristine; Vindesine | 1997 |
Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma.
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Calcium Channel Blockers; Cohort Studies; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorouracil; Gastrointestinal Diseases; Humans; Life Tables; Middle Aged; Neoplasm Proteins; Prospective Studies; Survival Analysis; Treatment Outcome; Verapamil; Vindesine | 2000 |
50 other study(ies) available for fluorouracil and vindesine
Article | Year |
---|---|
Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Retrospective Studies; Treatment Outcome; Vindesine | 1992 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Esophageal Neoplasms; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Stomach Neoplasms; Vindesine | 1992 |
Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation--5 year results.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Middle Aged; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Radionuclide Imaging; Remission Induction; Retrospective Studies; Vincristine; Vindesine | 1990 |
Subrenal capsule assay as a chemosensitivity test for primary esophageal squamous cell carcinoma.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cell Division; Esophageal Neoplasms; Female; Fluorouracil; Humans; Immunohistochemistry; Mice; Middle Aged; Neoplasm Transplantation; Organoplatinum Compounds; Peplomycin; Subrenal Capsule Assay; Time Factors; Vindesine | 1991 |
Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Analysis; Time Factors; Vindesine | 1991 |
[Neo-adjuvant chemotherapy with cisplatin, 5-fluorouracil, vindesine in head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Vindesine | 1992 |
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine | 1992 |
Cisplatin, vindesine, and 96-h continuous infusion of 5-fluorouracil as initial chemotherapy for locally advanced head and neck carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Synergism; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1991 |
[Current perspectives in the management of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Vinblastine; Vincristine; Vindesine | 1985 |
[Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Vindesine | 1988 |
[Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Female; Floxuridine; Fluorouracil; Humans; Methotrexate; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Vindesine | 1987 |
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Vindesine | 1988 |
[Chemotherapy of esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Humans; Vindesine | 1988 |
[Epidermoid cancers of the esophagus: combined chemotherapy, surgery and radiotherapy. Preliminary results in 50 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Vindesine | 1988 |
Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2).
Topics: Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line; Doxorubicin; Drug Synergism; Flow Cytometry; Fluorouracil; Humans; Mitoxantrone; Pancreatic Neoplasms; Vincristine; Vindesine | 1986 |
Phase II-study vindesine + 5-Fluoro-Uracil combination chemotherapy in advanced colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Evaluation; Fluorouracil; Humans; Rectal Neoplasms; Vindesine | 1986 |
[Phase II trial of an ambulatory treatment with 5-fluorouracil administered by continuous perfusion combined with vindesine and cyclophosphamide].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Kinetics; Middle Aged; Neoplasm Metastasis; Vindesine | 1986 |
[A case of non-resectable thymoma which responded to the administration of adriamycin, vindesine and 5-FU].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Vindesine | 1986 |
Angina pectoris associated with infusions of 5-FU and vindesine.
Topics: Aged; Angina Pectoris; Female; Fluorouracil; Humans; Middle Aged; Vindesine | 1986 |
Mitomycin-associated lung disease.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycins; Vinblastine; Vincristine; Vindesine | 1983 |
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Vinblastine; Vindesine | 1982 |
New possibilities of cytostatic drug testing on patient tumor cells by flow cytometry.
Topics: Antineoplastic Agents; Ascitic Fluid; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation, Preclinical; Esterases; Female; Flow Cytometry; Fluorouracil; Humans; Hydrogen-Ion Concentration; Inflammation; Methotrexate; Neoplastic Stem Cells; Ovarian Neoplasms; Pleural Effusion; Uterine Cervical Neoplasms; Vinblastine; Vindesine | 1984 |
Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukocyte Count; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Platelet Count; Prognosis; Rectal Neoplasms; Semustine; Thrombocytopenia; Vinblastine; Vindesine | 1982 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Forecasting; Humans; In Vitro Techniques; Lymphatic Metastasis; Melanoma; Methotrexate; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction; Retrospective Studies; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1994 |
Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Leukemia P388; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Mitomycin; Peplomycin; Vindesine | 1994 |
[Chemotherapy for metastatic brain tumors with CDDP and other agents: correlation between chemotherapeutic effects and the results of in vitro chemosensitivity tests using collagen gel-embedded culture combined with computerized image analysis in metastat
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Collagen; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Tumor Cells, Cultured; Vindesine | 1994 |
Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Tamoxifen; Treatment Failure; Vindesine | 1994 |
Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgical; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Incidence; Length of Stay; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycins; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Proportional Hazards Models; Remission Induction; Survival Rate; Time Factors; Vinblastine; Vindesine; Vinorelbine | 1994 |
[Multidisciplinary treatment of cancer of the esophagus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Esophagus; Fluorouracil; Humans; Radiotherapy Dosage; Survival Rate; Vindesine | 1993 |
Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Mastectomy, Segmental; Middle Aged; Mitoxantrone; Survival Rate; Vindesine | 1993 |
Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Vindesine | 1996 |
[Effective combined injection method of fluoropyrimidine and platinum--application for advanced esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Injections; Male; Methotrexate; Vinblastine; Vindesine | 1996 |
[Inoperable esophageal carcinoma managed by combined chemotherapy (CBDCA, 5-FU and VDS) and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheterization; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Radiotherapy Dosage; Survival Rate; Vindesine | 1997 |
Disruptions of the hypothalamo-pituitary-adrenal axis increase anticancer drug lethality in the rat.
Topics: Adrenalectomy; Animals; Antineoplastic Agents; Busulfan; Carmustine; Corticosterone; Cosyntropin; Cyclophosphamide; Fluorouracil; Hypophysectomy; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Rats; Rats, Wistar; Vindesine | 1997 |
[Therapy pf cervical lymph node metastases of unknown primary tumor].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vindesine | 1997 |
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Time Factors; Vindesine | 1999 |
[A case of stage IV esophageal cancer successfully treated by chemoradiation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Vindesine | 1999 |
[Postoperative complications after radiochemotherapy or chemotherapy for bronchial cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carcinoma, Bronchogenic; Cause of Death; Cisplatin; Etoposide; Female; Fluorouracil; Hospital Mortality; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Pneumonia; Radiotherapy, Adjuvant; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2000 |
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Paris; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Vindesine | 2002 |
[Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Maxilla; Maxillary Neoplasms; Mouth; Mouth Neoplasms; Paclitaxel; Teniposide; Tumor Cells, Cultured; Vindesine | 2002 |
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine | 2008 |
New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Topics: Adult; Age Factors; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Denmark; Disease Susceptibility; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Severity of Illness Index; Tamoxifen; Vindesine | 2008 |
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Calcium Channel Blockers; Cell Proliferation; Cisplatin; Dose Fractionation, Radiation; Doxorubicin; Drug Resistance, Neoplasm; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Radiation Tolerance; Spheroids, Cellular; Tumor Cells, Cultured; Verapamil; Vindesine; X-Rays | 2009 |
Management of inflammatory breast cancer after neoadjuvant chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Inflammatory Breast Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Survival Rate; Vinblastine; Vindesine; Vinorelbine | 2011 |
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Periodontitis; Prednisone; Retrospective Studies; Treatment Outcome; Vindesine | 2013 |
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |